Literature DB >> 30112998

Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.

Mahboobeh Razmkhah1, Shabnam Abtahi1, Abbas Ghaderi1,2.   

Abstract

Mesenchymal Stem Cells [MSCs] are a heterogeneous population of fibroblast-like cells which maintain self-renewability and pluripotency. Many studies have demonstrated the immunomodulatory effects of MSCs on the innate and adaptive immune cells. As a result of interactions with tumor cells, microenvironment and immune-stimulating milieu, MSCs contribute to tumor progression by several mechanisms, including sustained proliferative signal in cancer stem cells [CSCs], inhibition of tumor cell apoptosis, transition to tumor-associated fibroblasts [TAFs], promotion of angiogenesis, stimulation of epithelial-mesenchymal transition [EMT], suppression of immune responses, and consequential promotion of tumor metastasis. Here, we present an overview of the latest findings on Janusfaced roles that MSCs play in the tumor microenvironment [TME], with a concise focus on innate and adaptive immune responses. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Mesenchymal stem cells; adaptive immunezzm321990response; immunomodulation; innate immune response; metastasis; tumor microenvironment.

Mesh:

Year:  2019        PMID: 30112998     DOI: 10.2174/1574888X13666180816114809

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  8 in total

1.  Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.

Authors:  Koushan Sineh Sepehr; Alireza Razavi; Zuhair Mohammad Hassan; Abdolreza Fazel; Meghdad Abdollahpour-Alitappeh; Majid Mossahebi-Mohammadi; Mir Saeed Yekaninejad; Behrouz Farhadihosseinabadi; Seyed Mahmoud Hashemi
Journal:  Cancer Immunol Immunother       Date:  2020-04-30       Impact factor: 6.968

2.  Proteomics Study of Mesenchymal Stem Cell-Like Cells Obtained from Tumor Microenvironment of Patients with Malignant and Benign Salivary Gland Tumors.

Authors:  Mohammad Reza Haghshenas; Nasrollah Erfani; Soolmaz Khansalar; Bijan Khademi; Mohammad Javad Ashraf; Mahboobeh Razmkhah; Abbas Ghaderi
Journal:  Cell J       Date:  2022-04-27       Impact factor: 3.128

3.  The Legacy of Mesenchymal Stem Cells in Vindicating the Clonal Evolution Model of Cancer

Authors:  Shabnam Abtahi; Morvarid Asadipour; Abbas Ghaderi
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-28

4.  IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.

Authors:  Xiangrong Cui; Xuan Jing; Qin Yi; Zhongping Xiang; Jie Tian; Bin Tan; Jing Zhu
Journal:  Oncol Rep       Date:  2019-02-11       Impact factor: 3.906

5.  SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway.

Authors:  Jun Ding; Daming Qin; Yong Zhang; Qinghe Li; Yi Li; Jinmao Li
Journal:  Mol Med Rep       Date:  2020-01-03       Impact factor: 2.952

Review 6.  Treating Metastatic Brain Cancers With Stem Cells.

Authors:  Nadia Sadanandan; Alex Shear; Beverly Brooks; Madeline Saft; Dorothy Anne Galang Cabantan; Chase Kingsbury; Henry Zhang; Stefan Anthony; Zhen-Jie Wang; Felipe Esparza Salazar; Alma R Lezama Toledo; Germán Rivera Monroy; Joaquin Vega Gonzales-Portillo; Alexa Moscatello; Jea-Young Lee; Cesario V Borlongan
Journal:  Front Mol Neurosci       Date:  2021-11-24       Impact factor: 5.639

Review 7.  Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.

Authors:  Ting Shi; Ge Gao
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

Review 8.  New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma.

Authors:  Xingyu Chang; Zhanjun Ma; Guomao Zhu; Yubao Lu; Jingjing Yang
Journal:  J Bone Oncol       Date:  2021-06-23       Impact factor: 4.072

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.